Cardiff Oncology
CRDF
22 hedge funds and large institutions have $16M invested in Cardiff Oncology in 2014 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 6 closing their positions.
17% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 6
5% more funds holding
Funds holding: 21 → 22 (+1)
0.07% less ownership
Funds ownership: 18.56% → 18.49% (-0.07%)
0% less capital inflows, than outflows
Capital inflows: $1.66M | Capital outflows: $1.67M
67% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.A. Davidson & Co
Great Falls,
Montana
|
+$441K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$56.9K |
| 3 |
Paloma Partners
Greenwich,
Connecticut
|
+$53.3K |
| 4 |
PEAK6 Group
Chicago,
Illinois
|
+$36.2K |
| 5 |
Tower Research Capital (TRC)
New York
|
+$17.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$1.22M |
| 2 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$171K |
| 3 |
Denver Investment Advisors
Denver,
Colorado
|
-$152K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$71K |
| 5 |
BlackRock Fund Advisors
San Francisco,
California
|
-$19.5K |
CRDF Hedge Fund Activity: Q3 2014 in Review
22 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in Cardiff Oncology (CRDF) for Q3 2014, worth a combined $16M — up 30% from $12.3M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new CRDF positions and 6 closed out — a net gain of 1 holder — while 2 added to existing stakes and 6 trimmed.
The largest buyer was D.A. Davidson & Co, opening a new position worth an estimated $441K. The largest seller was Morgan Stanley, cutting an estimated $1.22M.
- 22 institutional investors held Cardiff Oncology (CRDF) as of Q3 2014, up from 21 in Q2 2014.
- Funds reported $16M of Cardiff Oncology stock for Q3 2014, up 30% quarter-over-quarter.
- 7 funds opened new Cardiff Oncology positions in Q3 2014 and 6 closed out, a net change of +1 holder.
- The largest Cardiff Oncology buyer in Q3 2014 was D.A. Davidson & Co, an estimated $441K added.
- The largest Cardiff Oncology seller in Q3 2014 was Morgan Stanley, an estimated $1.22M sold.
Based on aggregated 13F filings for Q3 2014.